Successful Recovery of Acute Renal Transplant Failure in Recurrent Hepatitis C Virus –Associated Membranoproliferative Glomerulonephritis
We report the case of a 63‐year‐old female HCV‐positive renal transplant patient with biopsy‐proven recurrence of MPGN in the renal graft 3 years after transplant. Because of rapid loss of transplant function and consecutive need for hemodialysis, we initiated a combined anti‐HCV–directed therapy regimen consisting of daclatasvir and simeprevir over 12 weeks. Viral clearance of HCV was obtained as early as 2 weeks after start of treatment. No adverse therapy‐associated side effects were observed, and immunosuppressive dosing remained unchanged. Importantly, graft function fully recovered and hemodialysis was stopped 2 mo after the end of daclatasvir/simeprevir treatment. We report the first case of successful recovery of dialysis‐dependent renal transplant failure after treatment of recurrent HCV‐associated MPGN in a kidney transplant recipient by curing the underlying HCV infection with a combination of novel DAAs.
Source: American Journal of Transplantation - Category: Transplant Surgery Authors: E. Schrezenmeier, K. Wu, F. Halleck, L. Liefeldt, S. Brakemeier, F. Bachmann, S. Kron, K. Budde, M. Duerr Tags: Case Report Source Type: research
More News: Dialysis | Glomerulonephritis | Hemodialysis | Hepatitis | Hepatitis C | Kidney Transplant | Kidney Transplantation | Transplant Surgery | Transplants | Urology & Nephrology